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Trichinella spiralis is a highly destructive parasitic nematode that invades and destroys intestinal epithelial cells, injures many
different tissues during its migratory phase, and occupies and transformsmyotubes during the final phase of its life cycle. We set
out to investigate the role in immunity of innate receptors for potential pathogen- or danger-associated molecular patterns
(PAMPs or DAMPs). Focusing on theMyD88-dependent receptors, which include Toll-like receptors (TLRs) and interleukin-1
(IL-1) family members, we found that MyD88-deficient mice expelled worms normally, while TLR2/4-deficient mice showed ac-
celerated worm expulsion, suggesting that MyD88 was active in signaling pathways for more than one receptor during intestinal
immunity. A direct role for PAMPs in TLR activation was not supported in a transactivation assay involving a panel of murine
and human TLRs. Mice deficient in the IL-1 family receptor for the DAMP, IL-33 (called ST2), displayed reduced intestinal Th2
responses and impaired mast cell activation. IL-33 was constitutively expressed in intestinal epithelial cells, where it became con-
centrated in nuclei within 2 days of infection. Nuclear localization was an innate response to infection that occurred in intestinal
regions where worms were actively migrating. Th2 responses were also compromised in the lymph nodes draining the skeletal
muscles of ST2-deficient mice, and this correlated with increased larval burdens in muscle. Our results support a mechanism in
which the immune system recognizes and responds to tissue injury in a way that promotes Th2 responses.
The parasitic nematode Trichinella spiralis induces potent Th2responses that both clear intestinal infections and regulate im-
munity in extraintestinal sites (1–5). The innate cellular and mo-
lecular drivers of Th2 immunity appear to vary among nematode
infections, and the identification of mechanisms that initiate Th2
responses continues to be an area of active research (reviewed in
reference 6). Key roles for pattern recognition receptors, including
Toll-like receptors (TLRs), Nod-like receptors (NLR), and C-type
lectins, have been described for Th2 responses (7–13), although a
central paradigm of Th2 activation that parallels that of TLR/in-
terleukin-12 (IL-12) and Th1 immunity has yet to be defined.
TLR4 has been implicated in Th2 immunity in several different
systems, including the response to parasitic worms, ovalbumin
(OVA)-lipopolysaccharide (LPS), and house dust mite allergen
(8, 14–17). In an indirect mechanism, eosinophil-derived neuro-
toxin promotes Th2 immunity by binding to TLR2 (18). MyD88 is
a signaling adaptor molecule that propagates the response to most
TLRs, as well as responses to IL-1 family members, including
IL-18 and IL-33 (19–21). MyD88 binds to the intracellular Toll/
IL-1 receptor (TIR) domain of these receptors (directly or via a
bridging adaptor such as MyD88-adaptor-like [MAL]), where
it initiates a signaling cascade that ultimately leads to the acti-
vation of proinflammatory genes by the transcription factor
NF-B (22, 23).
Trichinella spiralis is a highly destructive pathogen that is
cleared from the intestine by a Th2-driven mechanism that de-
pends upon mucosal mast cells (24, 25). Infection is initiated
when first-stage larvae (L1) invade the intestinal epithelium. As
they penetrate and move through epithelial cells, larvae and adult
worms release glycoproteins that bear both novel and conserved
glycan modifications (26–29). One of these glycans incorporates
the dideoxyhexose tyvelose (26, 30). Another dideoxyhexose, as-
carylose, is found in ascaroside lipids in nematodes across the
phylum Nematoda (31), suggesting potential for these molecules
to serve as pathogen-associated molecular patterns (PAMPs). A
second glycan modification in T. spiralis first-stage larvae incor-
porates phosphorylcholine. This structure is also found in filarial
worms and is documented to bind TLR4 (14).
Epithelial cells occupied by the worm do not survive, and mi-
grating larvae and adult worms leave behind trails of dead cells
(32). Adult female worms in the intestine release newborn larvae
that may migrate through a variety of tissues prior to finding skel-
etal muscle where they penetrate, occupy, and transform myo-
tubes. Thus, cellular injury and death are prominent features of all
aspects of T. spiralis infection, and both are known to influence
adaptive immunity in other contexts, for example, binding of host
cell actin by DNGR-1 on dendritic cells or macrophage uptake of
apoptotic neutrophils (33, 34).
Necrotic cells release so-called alarmins, or danger-associated
molecular patterns (DAMPs), such as IL-33 and high-mobility
group protein B1 (HMGB1), which can give rise to inflammation
(35–37). The receptor for IL-33 is ST2, a member of the IL-1
family of cytokine receptors (20, 38). Unlike other IL-1 family
cytokines, IL-33 is released in its active form by necrotic cells (36,
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39, 40). Normally found in epithelial and endothelial cells, adi-
pocytes, astrocytes, and airway smooth muscle cells, IL-33 may
also be detected in mast cells, dendritic cells, and monocytes under
inflammatory conditions (41–47).
We hypothesized that T. spiralis may promote Th2 immunity
in three ways: directly via engagement of host receptors by para-
site-derived molecular patterns, indirectly by enabling access of
intestinal microbiota to normally sequestered TLRs, or by the trig-
gering release of DAMPs by injured host cells. Our findings sup-
port a mechanism involving ST2, the receptor for IL-33, and show
that in the intestine, the early innate response of intestinal epithe-
lial cells (IECs) to T. spiralis infection includes redistribution of
IL-33 within cells. Late in infection, muscle larval burdens in ST2-
deficient mice were significantly higher than in wild-type controls,
suggesting that IL-33 is a key regulator that limits parasite survival.
MATERIALS AND METHODS
Mice and rats. All mouse strains were on a C57BL/6 background. TLR2/
4/, MyD88/, and MyD88/ littermates (provided by S. Akira,
Osaka, Japan) (48), C57BL/6, and RAG2/ mice (Taconic) were bred
and/or maintained at Cornell under specific pathogen-free conditions
according to AAALAC guidelines. Albino Oxford (AO) rats served as par-
asite donors. Rodents were infected at 7 to 10 weeks of age and euthanized
by CO2 inhalation, and blood was collected by cardiac puncture. Experi-
ments performed at Cornell University were approved by the IACUC.
ST2/ mice (provided by A. McKenzie, Cambridge, United King-
dom) (49) were bred and maintained at Trinity College Dublin in com-
pliance with Irish Department of Health and Children regulations and
with the approval of Trinity College Dublin’s BioResources ethical review
board.
Parasite and infections. Maintenance of Trichinella spiralis (pig
strain), L1 recovery, and intestinal worm or muscle larval burdens were
estimated as described previously (3, 50, 51). Mice were infected by oral
gavage with 400 L1. Crude L1 extract, excretory-secretory (ES) antigens,
and purified phosphorylcholine-bearing proteins were prepared as de-
scribed previously (27, 52).
Culture of leukocytes and cytokine ELISA. Cells from cervical lymph
nodes (CLN) or mesenteric lymph nodes (MLN) were cultured, and su-
pernatants were assayed for IL-4, IL-5, and IL-10 by enzyme-linked im-
munosorbent assay (ELISA), as described previously (53). Similar assays
were used for IL-13 (eBioscience, 2 g/ml capture clone ebio13A, 0.2
g/ml detection antibody clone eBio1316H) and IFN- (BD Biosciences,
1 g/ml capture antibody clone AN-18; eBioscience, 0.125 g/ml detec-
tion antibody clone XMG1.2), using recombinant cytokine standards
(eBioscience). Mouse mast cell protease-1 (mMCP-1) was measured in
serum by ELISA (eBioscience).
Histology. For evaluation of skeletal muscle, tongues were fixed in
formalin. Samples of small intestine were cut longitudinally, prepared as
Swiss rolls (54), and fixed in formalin. Proximal and distal small intestine
(SI) were collected as separate rolls. Immunohistochemistry (IHC) was
performed as previously described to detect inducible nitric oxide syn-
thase (iNOS) (53) or IL-33 (3 g/ml goat anti-IL-33 antibody [R&D Sys-
tems] with 0.6 g/ml biotinylated rabbit anti-goat antibody [Vector Lab-
oratories]) and mMCP-1 (5 g/ml rat anti-mMCP-1 antibody [R&D
Systems] with 1 g/ml biotinylated rabbit anti-rat antibody [Vector Lab-
oratories]). Cells positive for mMCP-1 were counted per crypt-villus unit
(CVU) for a minimum of 50 CVU per section. Microscopy was performed
using a BX51 microscope, and images were captured with Microsuite
Basic Edition software (Olympus).
Evaluation of nuclear IL-33. Histologic sections of intestine were
blind scored for nuclear localization of IL-33 in epithelial cells. Briefly, the
percentage of a given villus epithelium that demonstrated nuclear IL-33
staining was estimated to be 0 to 25%, 25 to 50%, 50 to 75%, or 75 to
100%. At least 100 villi were counted per section (proximal or distal SI of
a single mouse). The data are reported as the percentage of villi in each
FIG 1 The role of MyD88 in immunity to T. spiralis. MyD88/ mice and C57BL/6 littermates were infected orally with 400 L1, and data were collected on the
days indicated. (A) Intestinal worm burdens; (B) serum mMCP-1 concentrations; (C) jejunal mast cell numbers, as defined by mMCP-1 staining; (D) larval
burdens in muscle, 28 days postinfection. Values shown are means standard deviations (SD). ND, not detected.
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range for a given tissue section. Those values were assigned to the mouse,
and means were calculated for each group of mice.
TLR transactivation assay. HEK293 cells were transfected with an
NF-B luciferase reporter construct, a constitutive -galactosidase con-
struct (to control for transfection efficiency), and a plasmid encoding the
indicated TLR, as previously described (55). Cells were cultured overnight
with crude parasite extract (10g/ml), ES antigens (1g/ml), or purified
phosphorylcholine-bearing proteins (2 g/ml), each at the highest con-
centration determined by titration to be nontoxic for the cells. Data were
analyzed by determining the fold induction of NF-B luminescence rela-
tive to that of the -galactosidase control (relative light units [RLU]).
Peptidoglycan, poly(I:C), LPS, flagellin, loxoribine, CpG DNA, and pro-
filin were used as positive controls.
Antibiotic treatment.C57BL/6 mice were provided with drinking wa-
ter containing 0.5 mg/ml bacitracin and streptomycin (Sigma-Aldrich),
ad libitum, starting 1 week prior to T. spiralis infection. This protocol has
been previously characterized as clearing all culturable fecal bacteria (56).
To confirm antibiotic efficacy, fecal pellets were cultured on LB agar plates
under aerobic conditions, and results are reported as CFU per gram of
feces.
Quantitative RT-PCR. Longitudinal, 3-cm sections of jejunum and
ileum were collected from infected and uninfected C57BL/6 mice. Peyer’s
patches were removed, total RNA was isolated from the remaining tissue
following disruption in TRIzol (Invitrogen) with a handheld homoge-
nizer (Fisher Scientific), and cDNA was prepared (SuperScript III first-
strand cDNA synthesis system; Invitrogen). A sample lacking reverse
transcriptase served as a negative control. IL-33 expression was measured
with TaqMan quantitative reverse transcription-PCR (qRT-PCR) (CT
method) using an ABI Prism 7500 sequence detection system. HPRT ex-
pression (not shown) was not affected by infection and served as the
endogenous control. Primers and probes were purchased (Applied Bio-
systems).
Statistical analysis. Each experiment was performed at least twice
with 3 to 8 mice or samples per group. Data were analyzed using Student’s
t test or analysis of variance (ANOVA) with Tukey’s post hoc test for
multiple means. P values less than 0.05 were considered to be statistically
significant.
RESULTS
MyD88 is required for amplification of the Th2 cytokine re-
sponse to infection. To investigate a role for innate receptors in
the response to T. spiralis infection, we infected mice deficient in
MyD88. Adult worm expulsion, serum mMCP-1, and intestinal
FIG 2 Cytokine responses in the MLNs of MyD88/ mice. MLN cells were collected from infected mice on the days indicated. Cytokines were assayed in cell
cultures following stimulation with T. spiralis cAg. Values shown are means SD.
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mast cells were similar in MyD88/ mice and littermate controls
(Fig. 1A, B, and C). Muscle larval burdens were also similar be-
tween the two strains, confirming that MyD88 deficiency did not
alter the outcome of infection (Fig. 1D). Nevertheless, in cell cul-
tures from MyD88/ MLN, the canonical Th2 cytokines IL-4,
IL-5, and IL-13 were significantly diminished, as was IL-10, while
there was no difference in gamma interferon (IFN-) production
(Fig. 2). There were no differences in cytokine production be-
tween the groups in the absence of antigen stimulation; cytokines
in most unstimulated cultures were at or below the detection limit
of the ELISA (data not shown).
T. spiralis does not directly activate TLRs in vitro. In order to
determine whether MyD88-dependent enhancement of cytokine
responses was promoted by PAMPS interacting directly with
TLRs, we assayed extracts and purified glycoprotein preparations
from first-stage T. spiralis larvae in a TLR transactivation assay.
Crude extracts, containing both large and small molecules, did not
stimulate any of the human or mouse receptors included in the
panel (Fig. 3). We also tested the glycoprotein-rich excretory-se-
cretory products and phosphorylcholine-bearing glycoproteins
purified from first-stage larvae. All results were negative (not
shown), suggesting that the MyD88-dependent effect was not
driven by a direct interaction of larval molecular patterns with the
TLRs assayed.
Influence of the microbiota on Th2 immunity. To determine
FIG 3 TLR responses to T. spiralis extracts in vitro. Activation of mouse (A)
and human (B) TLRs by T. spiralis crude extract or the appropriate positive
control (see Materials and Methods) for each TLR in an HEK293 cell luciferase
reporter assay. Values are means SD. Each positive control was significantly
different from the negative control for that receptor (P	 0.05).
FIG 4 Effect of the intestinal microbiota and TLR2/4 on intestinal immunity to T. spiralis. (A to C) C57BL/6 mice were treated with bacitracin and streptomycin
for 7 days prior to oral infection with 400 L1 (on day 0), and data were collected on the days indicated. (A) Intestinal worm burdens; (B) cytokines in
cAg-restimulated MLN cell cultures; (C) fecal bacteria (CFU/g); (D and E) TLR2/4/ and C57BL/6 mice were infected with 400 L1; (D) intestinal worm burdens
at 12 days postinfection; (E) cytokines in cAg-restimulated MLN cells collected 12 days postinfection. Values shown are means SD.
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whether the results obtained in MyD88-deficient mice were at-
tributable to infection-induced disturbance of the intestinal mi-
crobiota such that microbes gained access to TLRs, we employed a
treatment regimen that has been reported to eliminate all cultur-
able bacteria from the intestine (56). Antibiotic treatment had no
effect on parasite expulsion (Fig. 4A) or IL-4 production in MLN
cultures (Fig. 4B). IFN- and IL-10 were not reduced significantly,
and IL-5 and IL-13 were reduced at a single time point, consistent
with a modest contribution of the intestinal microbiota toward
inducing the intestinal Th2 response to T. spiralis. We observed
that culturable fecal bacteria were effectively eliminated after 1
week of antibiotic treatment; however, T. spiralis infection in-
duced growth of antibiotic-resistant bacteria (Fig. 4C). A similar
pattern of bacterial clearance followed by infection-induced bac-
terial growth was observed in animals treated with enrofloxacin
(not shown). Compared with results of the bacitracin-streptomy-
cin treatment, enrofloxacin had an equally modest effect on Th2
cytokine production (not shown).
Because TLR2 and TLR4 bind bacterial products and have been
implicated as drivers of other Th2 responses, we infected mice
deficient in both receptors. In contrast to what was observed in
MyD88/ and antibiotic-treated mice, TLR2/4/ mice showed
accelerated worm expulsion (Fig. 4D), together with MLN cyto-
kine responses similar to wild-type mice (Fig. 4E). Taken together,
the results indicate that although TLRs are not directly activated in
a MyD88-dependent fashion by larval products, and intestinal
bacteria have only a modest influence on immunity, TLR2/4 are
influential (perhaps via MyD88-independent signaling) by limit-
ing rather than promoting intestinal immunity.
ST2/mice have impaired Th2 immunity. In the absence of
compelling evidence that TLRs promote Th2 immunity to T. spi-
ralis, we turned our attention to another MyD88-dependent re-
ceptor, the IL-33 receptor ST2 (19, 38). Similar to MyD88/
mice, ST2/mice displayed normal parasite expulsion (Fig. 5A).
(Although the number of intestinal worms recovered from both
strains did not decline significantly between days 12 and 15 of
infection in the experiment shown, a second experiment con-
firmed that there was no difference between the strains and that
worms were largely eliminated by day 15.) Unlike MyD88/
mice, serum mMCP-1 was reduced (Fig. 5B) consistent with an
influence of ST2 on mastocytosis or mast cell activation. Reduc-
tion of Th2 cytokine production by MLN cells was evident in
ST2/ mice, particularly for IL-5 and IL-13 (Fig. 6A).
In contrast to MyD88/ mice, larval burdens in the muscle
tissue of ST2/ mice were significantly higher than in those of
wild-type controls (Fig. 5C). This increase was associated with a
strongly diminished Th2 cytokine response by CLN cells (Fig. 6B).
Although IFN- production in the draining lymph node was not
increased in ST2/ mice relative to controls, the robust infiltra-
tion of infected tongue muscle by iNOS leukocytes in ST2/
mice (Fig. 5D) may indicate Th1 skewing in the local milieu. Over-
all, the impact on infection and immunity was greater for ST2
deficiency than MyD88 deficiency.
Cellular distribution of IL-33 is altered by infection. Tran-
scription of IL-33 in intestinal tissue was not upregulated by in-
fection (Fig. 7A); however, the distribution of IL-33 protein
within epithelial cells changed dramatically in regions where par-
asites were actively migrating (Fig. 7B). Prior to infection, IL-33 was
diffusely distributed in the cytoplasm of IECs, as well as some leuko-
cytes in the lamina propria. Two days after infection, IL-33 was con-
centrated in the nuclei of IECs. The change in the numbers of cells
that demonstrated nuclear localization was statistically significant in
FIG 5 The role of ST2 in protective immunity to T. spiralis. ST2/ and C57BL/6 mice were infected orally with 400 L1. (A) Intestinal worm burdens; (B) serum
mMCP-1 concentrations, 15 days postinfection; (C) muscle burdens at 28 days postinfection; (D) immunohistochemical detection of iNOS in the tongue
(muscle), 17 days postinfection. Filled arrows indicate areas of brown iNOS staining; hollow arrows indicate cross sections of larvae. Thin boxes show areas
included in zoom image (on right). Values shown are means SD.
Scalfone et al.
1358 iai.asm.org Infection and Immunity
 o
n
 O
ctober 7, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
the proximal SI by day 2 and in the distal SI by day 4 (Fig. 7C),
consistent with the distal migration of worms during the course of
infection (57). Epithelial IL-33 redistribution also occurred at day 4
postinfection in the proximal SI of RAG2/ (Fig. 7D), MyD88/,
and ST2/ (not shown) mice. Thus, nuclear concentration of IL-33
in IECs is an innate response that is not driven in an autocrine fash-
ion, is not triggered by MyD88-dependent signaling, and occurs in-
dependently of the adaptive immune response.
DISCUSSION
IL-4 is essential for efficient elimination of intestinal adult T. spi-
ralis (2). Although the threshold of Th2 response necessary for
expulsion of T. spiralis has not been defined, our findings suggest
that relatively weak responses are sufficient for normal worm ex-
pulsion. MyD88 deficiency weakened the Th2 response without
compromising parasite clearance. Interpretation of this result is
complicated by the fact that MyD88 serves as a signaling adaptor
for a variety of TLRs and IL-1 family receptors, and it is possible
that there are contradictory influences mediated by different re-
ceptors. For example, we found that TLR2/4/ mice expelled
worms more rapidly, while MyD88/ did not. In another exam-
ple, IL-18 is an IL-1 receptor family member that is known to
suppress mastocytosis and the Th2 cytokine response to T. spiralis
(21, 58); however, we found that another IL-1 receptor family
member, ST2, is necessary for the Th2 response to be fully mani-
fest. Thus, the more modest effects observed in MyD88/ mice
may represent the conflicting influences of molecules that sup-
press (e.g., IL-18, TLR2/4) and promote (e.g., IL-33) Th2 cytokine
and effector responses.
First-stageT. spiralis larvae initiate intestinal infection, making
FIG 6 Cytokine response of lymph node cells during infection of ST2/mice. (A) MLN cells were collected from infected mice on the days indicated. Cytokines
were assayed in cell cultures following stimulation withT. spiralis cAg. (B) Cytokines in cAg-restimulated cultures of CLN cells collected during muscle infection,
17 days postinfection. Values shown are means SD.
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first contact with the innate immune system. We did not find
evidence in support of direct activation of TLRs by larval extracts
(containing both large and small molecules), phosphorylcholine-
bearing glycoproteins, or ES products that are dominated by dide-
oxyhexose-bearing glycoproteins. Nevertheless, deficiency of
TLR2 and TLR4 did impact worm expulsion, demonstrating that
these receptors are engaged during T. spiralis infection. One hy-
pothesis regarding the mechanism of this TLR2/4-dependent ef-
fect is that impaired gut homeostasis in the absence of these TLRs
contributes to a “leaky gut,” thus promoting parasite expulsion.T.
spiralis infection occurs within the intestinal epithelial layer,
which is exposed to vast numbers of bacteria (100 trillion bacteria
representing 1,000 different species). Under homeostatic condi-
tions, intestinal bacteria do not promote intestinal inflammation
(59, 60), and most remain physically separated from the epithe-
lium by a 50-m zone maintained by the secreted antibacterial
lectin RegIII (61, 62). The destruction of the epithelial mono-
layer by T. spiralis would likely disturb this protective zone or
perhaps alter the composition of the microbiota, providing access
to intestinal cells for bacterial TLR ligands; however, our findings
document that dysbiosis (as we observed during antibiotic treat-
ment) had only a modest impact on local Th2 responses and no
effect on worm clearance from the intestine. The contradiction of
results from antibiotic treatment and TLR2/4/ mice may be
rationalized if TLR2 and TLR4 are activated by ligands other than
bacterial cell wall constituents during T. spiralis infection or if
their activation by bacteria is normally masked by more potent
innate responses, as described above. The dysbiosis we observed
during infection is not surprising given the many factors (e.g.,
diet, immune milieu) that are known to affect the composition of
the gut microbiota. It seems unlikely that bacteria were carried
into the mouse by the parasite, as there is no evidence that T.
spiralis carries bacterial symbionts; genomic studies performed on
larvae, prepared by the same protocol used here, failed to identify
bacterial sequences (63). It seems more probable that an existing
commensal strain was given the opportunity for robust growth in
the infected gut when competing, antibiotic-sensitive bacteria had
been eliminated.
Innate receptors may also recognize ligands released by host
cells when they are injured during cellular invasion and parasite
migration. Indeed, observations in ST2-deficient mice support a
role for DAMPs in promoting the Th2 response and parasite clear-
ance. T. spiralis worms are much larger than the epithelial cells
they invade, and they kill large numbers of cells as they migrate
(32, 64). IL-33 in the cytoplasm of epithelial cells would be re-
leased when worms penetrate, damage, and then vacate the cells.
Roles for ST2 and IL-33 have been tested in other parasitic
worm infections with variable results. Administration of recom-
binant IL-33 amplifies Th2 immunity to Trichuris muris (65). In
contrast, ST2/ mice infected with Nippostrongylus brasiliensis
manifest normal Th2 responses (66). Thus, it appears that the key
mediators of innate immunity vary among worm infections in a
manner similar to the variation in effector mechanisms that have
been documented for different parasites. These distinctive re-
sponses may reflect behaviors or properties intrinsic to each par-
asite or related to the distinct habitats they occupy.
Our results show that the robust Th2 cytokine response gener-
ated after T. spiralis infection of mice is dependent on ST2. Al-
though intestinal worms were expelled normally in ST2/ mice,
the concentration of a key mediator in worm expulsion, mMCP-1,
was reduced in sera of infected mice, consistent with a diminished
mast cell response. Furthermore, the number of larvae that colo-
nized and survived in the muscle was increased in ST2/ mice,
providing evidence that IL-33 binding to ST2 is important in lim-
iting extraintestinal parasite infection. The cytokine data support
a role for IL-33 in promoting Th2 responses during the muscle
phase of infection and correlate with an increase in production of
iNOS (a Th1-associated tissue mediator) at sites of infection. In
FIG 7 IL-33 gene expression and protein distribution in the small intestine during T. spiralis infection. (A) IL-33 mRNA isolated from the jejunum and ileum
of infected C57BL/6 mice was measured using TaqMan qRT-PCR. Values shown are means  SD. (B) Immunohistochemical detection of intestinal IL-33
showing nuclear concentration of IL-33 during infection of the SI. (C) Quantification of epithelial cells per villus displaying nuclear IL-33, expressed as the
percentage of total villi counted in the proximal and distal small intestines of C57BL/6 mice. (D) Quantification of epithelial cells per villus displaying nuclear
IL-33 in the proximal SI of RAG2/ and control mice. Values shown are means SD. *, P	 0.05; **, P	 0.01; ***, P	 0.001 compared to day 0.
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other mouse strains (e.g., the Phil, dblGATA, and IL-10/
strains), local iNOS production is associated with reduced parasite
survival in the muscle rather than increased parasite burdens (4,
5). Thus, the ST2-dependent pathways that promote parasite con-
trol in the muscle may be more robust in the absence of excess
iNOS. In ST2/mice, the increase in muscle larvae did not result
from prolonged survival of adult worms in the intestine, as worm
expulsion was normal. It is possible that there are ST2-dependent
effects on worm fecundity. Immune responses that limit fecundity
have been documented (67, 68) but are poorly understood. Alter-
natively, ST2 may affect the migration of newborn T. spiralis lar-
vae to skeletal muscle. Newborn larvae are the most destructive of
the life stages, causing injury in many tissues, and release of IL-33
during their migration is likely. The influence of IL-33 on fecun-
dity and migration of newborn larvae merits testing.
In contrast to mice infected with Trichuris muris, in which
IL-33 mRNA expression increases in the cecum (65), we observed
constitutive expression of IL-33 in the small intestine. Gene ex-
pression was unaffected by T. spiralis infection, and IL-33 protein
was detected mainly in IECs and lamina propria leukocytes. Fol-
lowing epithelial cell invasion by the parasite, IL-33 became con-
centrated in the nuclei of IECs that were in the vicinity of migrat-
ing worms but were not invaded by them. A similar cellular
distribution of IL-33 has been observed in the human intestine,
where IL-33 is present in the cytoplasm of IECs in healthy indi-
viduals but is concentrated in nuclei during ulcerative colitis (69).
IL-33 has also been detected in nuclei of epithelial cells in the lungs
of both uninfected and parasite-infected mice (70). The signifi-
cance of nuclear concentration of IL-33 has not yet been docu-
mented, although the phenomenon is consistent with an innate
response that sequesters the cytokine or with a mechanism of gene
regulation in affected cells.
We observed that the transition from cytoplasmic to nuclear
localization in vivo did not require ST2 or MyD88, indicating that
this response is not a feedback loop by which IL-33 stimulation of
ST2 directly leads to suppression of the pathway. Nuclear localiza-
tion occurred in RAG/ mice, confirming it to be an innate
mechanism. Further studies are necessary to define the nuclear
functions of IL-33 in intestinal epithelia and to determine whether
nuclear IL-33 constitutes a defensive response in the mucosa that
operates independently of ST2. One possibility is that IL-33 accu-
mulates in the nuclei of dying cells; we have investigated the asso-
ciation between IEC cell death and nuclear concentration of IL-33
in vitro by using a parasite invasion assay that we have previously
described (64). We found that cells with nuclear propidium iodide
staining did not demonstrate nuclear IL-33 (data not shown).
We did not observe nuclear IL-33 in IEC in the large intestine
(data not shown) nor did redistribution occur in vitro when IL-
33-expressing DLD-1 cells were infected with T. spiralis larvae
(experiments performed as described in references 28 and 64)
(L. K. Scalfone and J. A. Appleton, unpublished data). Factors
intrinsic to the SI may be required to transmit the signal that
induces IL-33 to concentrate in IEC nuclei. Nuclear IL-33 was
observed along the length of the villus, although the parasite mi-
grates primarily at the crypt-villus junction, suggesting that IECs
damaged by migrating larvae or worms may release other mole-
cules that stimulate healthy IECs to concentrate IL-33 in their
nuclei.
It is widely accepted that Th2 responses support wound healing
and are induced by tissue injury resulting from a variety of causes.
Tissue injury is a prominent feature of trichinellosis. Although an
influence of parasite-derived molecular patterns on Th2 immu-
nity to T. spiralis was not supported by our data, our findings are
consistent with a role for tissue and cell damage in promoting Th2
responses during intestinal and extraintestinal phases of infection
and with an important role for ST2 in responding to this injury.
Infection with T. spiralis provides a robust, natural model for in-
vestigating the influence of cellular injury on immunity and the
role that IL-33 plays in the innate and adaptive responses to par-
asitic worms.
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